Insulet Analyst Price Targets - Benzinga

Insulet Corp

PODDNASDAQ

Trade with Public

Trade with Public

$142.28

-5.20-3.53%

At close: Sep 8, 5:00 PM EST

$142.28

N/A

After Hours: 4:03 PM EST

Overview News Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Compare Options Stock Report

Insulet Analyst Price Targets

Wall Street analyst price targets and consensus rating for Insulet (PODD).

Price Target Range — 8 Quarters

Analyst Consensus — 25 Analysts

16Buy

8Hold

1Sell

Consensus RatingBuy# Analysts25Avg. Consensus PT$245Upside to Avg. PT+72.1%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 6, 2026	Canaccord Genuity	William Plovanic	PT Cut	Buy	$249→$179
Aug 6, 2026	Leerink Partners	Mike Kratky	Downgrade	Outperform→Market Perform	$247→$145
Aug 6, 2026	TD Cowen	Mathew Blackman	PT Cut	Hold	$294→$144
Aug 6, 2026	UBS	Patrick Wood	PT Cut	Neutral	$174→$150
Aug 6, 2026	RBC Capital	Shagun Singh	PT Cut	Outperform	$245→$160
Aug 6, 2026	Bernstein	Lee Hambright	PT Cut	Outperform	$200→$175
Aug 6, 2026	Truist Securities	Richard Newitter	Downgrade	Buy→Hold	$210→$153
Aug 6, 2026	Benchmark	Bruce D. Jackson	PT Cut	Buy	$250→$185
Aug 6, 2026	Stifel	Jonathan Block	PT Cut	Buy	$225→$180
Aug 6, 2026	Wells Fargo	Lawrence Biegelsen	Downgrade	Overweight→Equal-Weight	$255→$144
Aug 6, 2026	JP Morgan	Robbie Marcus	Downgrade	Overweight→Neutral	$275→$152
Aug 6, 2026	BTIG	Marie Thibault	Downgrade	Buy→Neutral	—
Jul 28, 2026	UBS	Patrick Wood	Assumes	Buy→Neutral	$174
Jul 13, 2026	Truist Securities	Richard Newitter	PT Cut	Buy	$219→$210
Jul 13, 2026	RBC Capital	Shagun Singh	PT Cut	Outperform	$280→$245
Jul 10, 2026	Stifel	Jonathan Block	PT Cut	Buy	$250→$225
Jul 8, 2026	Citigroup	Joanne Wuensch	PT Raise	Neutral	$165→$172
Jul 6, 2026	Evercore ISI Group	Daniel Markowitz	PT Cut	Outperform	$200→$180
Jun 23, 2026	Deutsche Bank	Kieran Ryan	Initiate	Buy	$190
Jun 12, 2026	Truist Securities	Richard Newitter	PT Cut	Buy	$250→$219

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Canaccord Genuity Maintains Buy on Insulet, Lowers Price Target to $179

Canaccord Genuity analyst William Plovanic maintains Insulet (NASDAQ:PODD) with a Buy and lowers the price target from $249 to $179.

Benzinga Newsdesk

PRO
Leerink Partners Downgrades Insulet to Market Perform, Lowers Price Target to $145

Leerink Partners analyst Mike Kratky downgrades Insulet (NASDAQ:PODD) from Outperform to Market Perform and lowers the price target from $247 to $145.

Benzinga Newsdesk

PRO
TD Cowen Maintains Hold on Insulet, Lowers Price Target to $144

TD Cowen analyst Mathew Blackman maintains Insulet (NASDAQ:PODD) with a Hold and lowers the price target from $294 to $144.

Benzinga Newsdesk

PRO
UBS Maintains Neutral on Insulet, Lowers Price Target to $150

UBS analyst Patrick Wood maintains Insulet (NASDAQ:PODD) with a Neutral and lowers the price target from $174 to $150.

Benzinga Newsdesk

PRO
RBC Capital Maintains Outperform on Insulet, Lowers Price Target to $160

RBC Capital analyst Shagun Singh maintains Insulet (NASDAQ:PODD) with a Outperform and lowers the price target from $245 to $160.

Benzinga Newsdesk

PRO
Bernstein Maintains Outperform on Insulet, Lowers Price Target to $175

Bernstein analyst Lee Hambright maintains Insulet (NASDAQ:PODD) with a Outperform and lowers the price target from $200 to $175.

Benzinga Newsdesk